Summary
GlobalData's clinical trial report, “Typhoid Fever Global Clinical Trials Review, H1, 2016" provides an overview of Typhoid Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Typhoid Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Prokarium Limited
Novartis AG
Emergent BioSolutions Inc.
Bharat Biotech International Limited
GlaxoSmithKline Plc
Sanofi
Akums Drugs & Pharmaceuticals Limited
Accelovance Inc.
Avant Immunotherapeutics, Inc
Associated Biotech Pvt Ltd
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Typhoid Fever to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Typhoid Fever to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Typhoid Fever Therapeutics Clinical Trials 26
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 59
Abbreviations 59
Definitions 59
Research Methodology 60
Secondary Research 60
About GlobalData 61
Contact Us 61
Disclaimer 61
Source 62
List of Tables
Typhoid Fever Therapeutics, Global, Clinical Trials by Region, 2016* 6
Typhoid Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Typhoid Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Typhoid Fever Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Typhoid Fever Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Typhoid Fever Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Typhoid Fever Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 12
Proportion of Typhoid Fever to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13
Typhoid Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Typhoid Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Typhoid Fever to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16
Typhoid Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Typhoid Fever Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Typhoid Fever Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Typhoid Fever Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
Typhoid Fever Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Typhoid Fever Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Typhoid Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Typhoid Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
Typhoid Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Typhoid Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Typhoid Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
List of Figures
Typhoid Fever Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Typhoid Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Typhoid Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Typhoid Fever Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Typhoid Fever Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Proportion of Typhoid Fever to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13
Typhoid Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Typhoid Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Typhoid Fever to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16
Typhoid Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Typhoid Fever Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Typhoid Fever Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Typhoid Fever Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
Typhoid Fever Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Typhoid Fever Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Typhoid Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Typhoid Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
Typhoid Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Typhoid Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Typhoid Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 60
